NEW YORK, May 12 (GenomeWeb News) - Ingenium Pharmaceuticals has acquired two patents relating to generating rodent models from Incyte, the company said today.
The patents, US patent No. 5,994,075 and US patent No. 6,015,670, enable Ingenium to provide mouse and rat models developed using its Ingenotyping technology to partners in the US. Previously, Munich-based Ingenium held a license to the patents.